Adoptive cell therapy with tumor-infiltrating lymphocytes in patients with metastatic ovarian cancer: a pilot study.
Saved in:
| Title: | Adoptive cell therapy with tumor-infiltrating lymphocytes in patients with metastatic ovarian cancer: a pilot study. |
|---|---|
| Authors: | Pedersen M; Center for Cancer Immune Therapy, Department of Hematology, Herlev Hospital, University of Copenhagen, Herlev, Denmark.; Department of Oncology, Herlev Hospital, University of Copenhagen, Herlev, Denmark., Westergaard MCW; Center for Cancer Immune Therapy, Department of Hematology, Herlev Hospital, University of Copenhagen, Herlev, Denmark., Milne K; Deeley Research Centre, BC Cancer, Victoria, Canada., Nielsen M; Center for Cancer Immune Therapy, Department of Hematology, Herlev Hospital, University of Copenhagen, Herlev, Denmark.; Department of Oncology, Herlev Hospital, University of Copenhagen, Herlev, Denmark., Borch TH; Center for Cancer Immune Therapy, Department of Hematology, Herlev Hospital, University of Copenhagen, Herlev, Denmark.; Department of Oncology, Herlev Hospital, University of Copenhagen, Herlev, Denmark., Poulsen LG; Department of Gynecology and Obstetrics, Herlev Hospital, University of Copenhagen, Herlev, Denmark., Hendel HW; Department of Clinical Physiology and Nuclear Medicine, Herlev Hospital, University of Copenhagen, Herlev, Denmark., Kennedy M; Deeley Research Centre, BC Cancer, Victoria, Canada., Briggs G; Deeley Research Centre, BC Cancer, Victoria, Canada., Ledoux S; Deeley Research Centre, BC Cancer, Victoria, Canada., Nøttrup TJ; Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Andersen P; Department of Clinical Immunology and Stem Cell Facility, Herlev Hospital, University of Copenhagen, Herlev, Denmark., Hasselager T; Department of Pathology, Herlev Hospital, University of Copenhagen, Herlev, Denmark., Met Ö; Center for Cancer Immune Therapy, Department of Hematology, Herlev Hospital, University of Copenhagen, Herlev, Denmark.; Department of Oncology, Herlev Hospital, University of Copenhagen, Herlev, Denmark., Nelson BH; Deeley Research Centre, BC Cancer, Victoria, Canada.; Department of Medical Genetics, University of British Columbia, Vancouver, Canada., Donia M; Center for Cancer Immune Therapy, Department of Hematology, Herlev Hospital, University of Copenhagen, Herlev, Denmark.; Department of Oncology, Herlev Hospital, University of Copenhagen, Herlev, Denmark., Svane IM; Center for Cancer Immune Therapy, Department of Hematology, Herlev Hospital, University of Copenhagen, Herlev, Denmark.; Department of Oncology, Herlev Hospital, University of Copenhagen, Herlev, Denmark. |
| Source: | Oncoimmunology [Oncoimmunology] 2018 Sep 26; Vol. 7 (12), pp. e1502905. Date of Electronic Publication: 2018 Sep 26 (Print Publication: 2018). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Print ISSN: 2162-4011 (Print) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 30524900 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Adoptive cell therapy with tumor-infiltrating lymphocytes in patients with metastatic ovarian cancer: a pilot study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Pedersen+M%22">Pedersen M</searchLink>; Center for Cancer Immune Therapy, Department of Hematology, Herlev Hospital, University of Copenhagen, Herlev, Denmark.; Department of Oncology, Herlev Hospital, University of Copenhagen, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Westergaard+MCW%22">Westergaard MCW</searchLink>; Center for Cancer Immune Therapy, Department of Hematology, Herlev Hospital, University of Copenhagen, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Milne+K%22">Milne K</searchLink>; Deeley Research Centre, BC Cancer, Victoria, Canada.<br /><searchLink fieldCode="AU" term="%22Nielsen+M%22">Nielsen M</searchLink>; Center for Cancer Immune Therapy, Department of Hematology, Herlev Hospital, University of Copenhagen, Herlev, Denmark.; Department of Oncology, Herlev Hospital, University of Copenhagen, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Borch+TH%22">Borch TH</searchLink>; Center for Cancer Immune Therapy, Department of Hematology, Herlev Hospital, University of Copenhagen, Herlev, Denmark.; Department of Oncology, Herlev Hospital, University of Copenhagen, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Poulsen+LG%22">Poulsen LG</searchLink>; Department of Gynecology and Obstetrics, Herlev Hospital, University of Copenhagen, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Hendel+HW%22">Hendel HW</searchLink>; Department of Clinical Physiology and Nuclear Medicine, Herlev Hospital, University of Copenhagen, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Kennedy+M%22">Kennedy M</searchLink>; Deeley Research Centre, BC Cancer, Victoria, Canada.<br /><searchLink fieldCode="AU" term="%22Briggs+G%22">Briggs G</searchLink>; Deeley Research Centre, BC Cancer, Victoria, Canada.<br /><searchLink fieldCode="AU" term="%22Ledoux+S%22">Ledoux S</searchLink>; Deeley Research Centre, BC Cancer, Victoria, Canada.<br /><searchLink fieldCode="AU" term="%22Nøttrup+TJ%22">Nøttrup TJ</searchLink>; Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Andersen+P%22">Andersen P</searchLink>; Department of Clinical Immunology and Stem Cell Facility, Herlev Hospital, University of Copenhagen, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Hasselager+T%22">Hasselager T</searchLink>; Department of Pathology, Herlev Hospital, University of Copenhagen, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Met+Ö%22">Met Ö</searchLink>; Center for Cancer Immune Therapy, Department of Hematology, Herlev Hospital, University of Copenhagen, Herlev, Denmark.; Department of Oncology, Herlev Hospital, University of Copenhagen, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Nelson+BH%22">Nelson BH</searchLink>; Deeley Research Centre, BC Cancer, Victoria, Canada.; Department of Medical Genetics, University of British Columbia, Vancouver, Canada.<br /><searchLink fieldCode="AU" term="%22Donia+M%22">Donia M</searchLink>; Center for Cancer Immune Therapy, Department of Hematology, Herlev Hospital, University of Copenhagen, Herlev, Denmark.; Department of Oncology, Herlev Hospital, University of Copenhagen, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Svane+IM%22">Svane IM</searchLink>; Center for Cancer Immune Therapy, Department of Hematology, Herlev Hospital, University of Copenhagen, Herlev, Denmark.; Department of Oncology, Herlev Hospital, University of Copenhagen, Herlev, Denmark. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101570526%22">Oncoimmunology</searchLink> [Oncoimmunology] 2018 Sep 26; Vol. 7 (12), pp. e1502905. <i>Date of Electronic Publication: </i>2018 Sep 26 (<i>Print Publication: </i>2018). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101570526 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2162-4011 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221624011%22">21624011 </searchLink><i>NLM ISO Abbreviation: </i>Oncoimmunology <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30524900 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/2162402X.2018.1502905 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e1502905 Titles: – TitleFull: Adoptive cell therapy with tumor-infiltrating lymphocytes in patients with metastatic ovarian cancer: a pilot study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Pedersen M – PersonEntity: Name: NameFull: Westergaard MCW – PersonEntity: Name: NameFull: Milne K – PersonEntity: Name: NameFull: Nielsen M – PersonEntity: Name: NameFull: Borch TH – PersonEntity: Name: NameFull: Poulsen LG – PersonEntity: Name: NameFull: Hendel HW – PersonEntity: Name: NameFull: Kennedy M – PersonEntity: Name: NameFull: Briggs G – PersonEntity: Name: NameFull: Ledoux S – PersonEntity: Name: NameFull: Nøttrup TJ – PersonEntity: Name: NameFull: Andersen P – PersonEntity: Name: NameFull: Hasselager T – PersonEntity: Name: NameFull: Met Ö – PersonEntity: Name: NameFull: Nelson BH – PersonEntity: Name: NameFull: Donia M – PersonEntity: Name: NameFull: Svane IM IsPartOfRelationships: – BibEntity: Dates: – D: 26 M: 09 Text: 2018 Sep 26 Type: published Y: 2018 Identifiers: – Type: issn-print Value: 2162-4011 Numbering: – Type: volume Value: 7 – Type: issue Value: 12 Titles: – TitleFull: Oncoimmunology Type: main |
| ResultId | 1 |